Granite Islands Private Wealth’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.2M Buy
8,796
+160
+2% +$34.4K 1.63% 17
2026
Q1
$1.87M Buy
8,636
+1,067
+14% +$237K 1.72% 16
2025
Q4
$1.72M Buy
+7,569
New +$1.72M 1.58% 18

Other funds holding ABBV

Granite Islands Private Wealth's ABBV Position: Q2 2026 in Review

Granite Islands Private Wealth increased its AbbVie (ABBV) stake by 1.9% in Q2 2026, buying an estimated $34.4K and bringing the position to 8,796 shares worth $2.2M. The position accounts for 1.63% of the portfolio, ranked #17.

Granite Islands Private Wealth first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 4,208 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Granite Islands Private Wealth held 8,796 shares of AbbVie worth $2.2M as of Q2 2026.
  • Granite Islands Private Wealth bought 160 AbbVie shares in Q2 2026, an estimated $34.4K.
  • AbbVie made up 1.63% of Granite Islands Private Wealth's portfolio in Q2 2026, its #17 holding.
  • Granite Islands Private Wealth first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • 4,208 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Granite Islands Private Wealth's 13F filing for Q2 2026, filed 21 Jul 2026.